摘要
目的:探讨甲状腺癌患者不同治疗方法彩超声像学改变和血清可溶性白介素-2受体(sIL-2R)的关系。方法:100例甲状腺癌患者分组治疗前后检测彩超声像学和sIL-2R含量的改变。结果:治疗后甲状腺肿块表现回声均匀(30)和境界清楚(49)的例数均有所增加(P<0.05),回声不均匀(70)和边界不清楚的例数(51)都有所减少(P<0.01);sIL-2R含量均低于治疗前(P<0.05)。结论:彩超声像学改变和sIL-2R含量检测对评价甲状腺癌疗效有一定意义。
Objective To explore the relationship of color ultrasonography and the level of Soluble Interleukin-2 Receptor(sIL-2R) in patients with thyroid carcinoma.Methods Color ultrasonography and Enzyme linked Immunosorbent Assay(ELISA) method were used to observe 100 cases in thyroid carcinoma.Results The cases which showed echo symmetry and boundary clarity with thyroid carcinoma were increased after therapy;while the cases which showed echo asymmetric and boundary unsharpness were decreased; The level of sIL-2R post-therapy was higher than that pretherapy.Conclusions The use of color ultrasonography and measurement of sIL-2R are of definite significance in evaluating therapeutic effect in thyroid carcinoma.
出处
《郧阳医学院学报》
2005年第3期159-160,共2页
Journal of Yunyang Medical College
关键词
甲状腺肿瘤
SIL-2R
治疗
Soluble Interleukin-2 Receptor
thyroid carcinoma
treatment